Inventor · disambiguated record
Adam Judge
Also filed as: JUDGE ADAM · JUDGE ADAM DANIEL
24 granted patents·20 pending applications·1,714 citations·filing 2005–2024
97Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC15ARBUTUS BIOPHARMA CORP11MACLACHLAN IAN7ABDERA THERAPEUTICS INC2GENEVANT SCIENCES GMBH2
Top patents by PatentIndex Score
44 records- 0199US9074208B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Jul 7, 2015·94 cites·44 claims
- 0299US8513403B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2012·Granted Aug 20, 2013·114 cites·27 claims
- 0399US8101741B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2006·Granted Jan 24, 2012·252 cites·43 claims
- 0499US7915399B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2007·Granted Mar 29, 2011·148 cites·11 claims
- 0598US12016929B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Jun 25, 2024·5 cites·22 claims
- 0698US11786598B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Oct 17, 2023·7 cites·17 claims
- 0798US9878042B2Lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·23 cites·18 claims
- 0898US8283333B2Lipid formulations for nucleic acid deliveryYAWORSKI ED·Filed 2010·Granted Oct 9, 2012·313 cites·39 claims
- 0998US8188263B2Modified siRNA molecules and uses thereofMACLACHLAN IAN·Filed 2009·Granted May 29, 2012·241 cites·28 claims
- 1097US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 1197US7807815B2Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·68 cites·28 claims
- 1296US8236943B2Compositions and methods for silencing apolipoprotein BLEE AMY C H·Filed 2010·Granted Aug 7, 2012·234 cites·26 claims
- 1396US8227443B2Silencing of CSN5 gene expression using interfering RNAMACLACHLAN IAN·Filed 2010·Granted Jul 24, 2012·31 cites·20 claims
- 1495US11446383B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Sep 20, 2022·6 cites·17 claims
- 1595US11191849B2Compositions and methods for delivering messenger RNAARBUTUS BIOPHARMA CORP·Filed 2017·Granted Dec 7, 2021·10 cites·10 claims
- 1695US8598333B2SiRNA silencing of genes expressed in cancerMACLACHLAN IAN·Filed 2007·Granted Dec 3, 2013·27 cites·8 claims
- 1793US9006191B2Silencing of polo-like kinase expression using interfering RNAMACLACHLAN IAN·Filed 2008·Granted Apr 14, 2015·19 cites·41 claims
- 1892US12043833B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 1992US2024316206A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2091US11427823B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Aug 30, 2022·5 cites·16 claims
- 2190US8865675B2Compositions and methods for silencing apolipoprotein BHEYES JAMES·Filed 2011·Granted Oct 21, 2014·12 cites·46 claims
- 2290US8716464B2Compositions and methods for silencing Ebola virus gene expressionGEISBERT THOMAS W·Filed 2010·Granted May 6, 2014·11 cites·20 claims
- 2388US2024100166A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 2482US2025179496A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2572US2018071397A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2667US2013122104A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsYAWORSKI ED·Filed 2012·Application pending·0 cites
- 2766US2022160899A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 2858US12344675B2Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complexABDERA THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·30 claims
- 2957US2014161894A1Sirna silencing of genes expressed in cancerALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3056US2007054873A1Glucocorticoid modulation of nucleic acid-mediated immune stimulationPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3155US2016264971A1Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3254US12251470B2Lipid nanoparticle formulationsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Mar 18, 2025·0 cites·10 claims
- 3354US2022031847A1Therapeutic methodsGENEVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 3454US2024207462A1Immunoconjugates for targeted radioisotope therapyABDERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3553US2013178511A1Silencing of csn5 gene expression using interfering rnaMACLACHLAN IAN·Filed 2012·Application pending·0 cites
- 3651US2022168222A1Lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 3751US2006134189A1siRNA silencing of apolipoprotein BPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3850US2011224418A1MODIFIED sIRNA MOLECULES AND USES THEREOFPROTIVA BIOTHERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 3948US2011189300A1siRNA SILENCING OF APOLIPOPROTEIN BPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4047US2008171716A1Nucleic acid modulation of toll-like receptor-mediated immune stimulationPROTIVA BIOTHERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4142US2016115483A1Silencing of polo-like kinase expression using interfering rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4241US2013022649A1Snalp formulations containing antioxidantsPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4340US9222086B2Compositions and methods for silencing genes expressed in cancerJUDGE ADAM·Filed 2010·Granted Dec 29, 2015·0 cites·8 claims
- 4436US2011071208A1Lipid encapsulated dicer-substrate interfering rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Judge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →